Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[Quality of life in multiple sclerosis--association with clinical features, fatigue and depressive syndrome].
[Natalizumab as induction therapy in multiple sclerosis.]
Glatiramer acetate: a review of its use in patients with relapsing-remitting multiple sclerosis and in delaying the onset of clinically definite multiple sclerosis.
Distinct serum apolipoprotein A-I levels in neuromyelitis optica and acute transverse myelitis.
Promoting return of function in multiple sclerosis: An integrated approach.
Demyelination during multiple sclerosis is associated with combined activation of microglia/macrophages by IFN-γ and alpha B-crystallin.
Two decades of subcutaneous glatiramer acetate injection: current role of the standard dose, and new high-dose low-frequency glatiramer acetate in relapsing-remitting multiple sclerosis treatment.
Multiple sclerosis: Teriflunomide shows efficacy as an add-on therapy to IFN-β in patients with multiple sclerosis.
Two assessments to evaluate imagery ability: translation, test-retest reliability and concurrent validity of the German KVIQ and Imaprax.
Transverse myelitis secondary to Melioidosis; A case report.
Differentiation of neuromyelitis optica from multiple sclerosis in a cohort from the mainland of China.
Cardiovascular effects of fingolimod: A review article.
The risk of cancer from azathioprine as a treatment for multiple sclerosis.
Anthocyanins suppress the secretion of proinflammatory mediators and oxidative stress, and restore ion pump activities in demyelination.
Directed Differentiation of Oligodendrocyte Progenitor Cells From Mouse Induced Pluripotent Stem Cells.
[Stem cell transplantation for multiple sclerosis : Hamburg experiences and state of international research].
Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis.
NG2, a common denominator for neuroinflammation, blood-brain barrier alteration, and oligodendrocyte precursor response in EAE, plays a role in dendritic cell activation.
Burden of illness in multiple sclerosis (DEFENSE) study: the costs and quality-of-life of Finnish patients with multiple sclerosis.
[Prognostic value of aquaporin-4 antibody in patients of inflammatory demyelinating diseases in central nervous system].
C16 peptide shown to prevent leukocyte infiltration and alleviate detrimental inflammation in acute allergic encephalomyelitis model.
Oculopalatal tremor in multiple sclerosis with spontaneous resolution.
Regulation: The FDA is overcautious on consumer genomics.
Oligodendroglia in cortical multiple sclerosis lesions decrease with disease progression, but regenerate after repeated experimental demyelination.
Does GRK-β arrestin machinery work as a "switch on" for GPR17-mediated activation of intracellular signaling pathways?

Pages